Table of Contents Author Guidelines Submit a Manuscript
Pathology Research International
Volume 2011, Article ID 825627, 4 pages
http://dx.doi.org/10.4061/2011/825627
Research Article

Should Histologic Grade Be Incorporated into the TNM Classification System for Small (T1, T2) Node-Negative Breast Adenocarcinomas?

1Department of Pathology & Laboratory Medicine, Chandler Medical Center, College of Medicine, University of Kentucky, 800 Rose Street, MS 129, Lexington, KY 40536, USA
2Department of Behavioral Sciences, University of Kentucky, Lexington, KY 40506, USA
3Comprehensive Breast Care Center, Markey Cancer Center, Lexington, KY 40536, USA

Received 14 September 2010; Accepted 8 October 2010

Academic Editor: Rohit Bhargava

Copyright © 2011 Mathew Purdom et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Joint Committee on Cancer, AJCC Cancer Staging Manual, chapter 32, Springer, Berlin, Germany, 7th edition, 2010.
  2. P. L. Fitzgibbons, D. L. Page, and D. Weaver, “Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999,” Archives of Pathology & Laboratory Medicine, vol. 124, pp. 966–978, 2000. View at Google Scholar
  3. F. Tavassoli and P. Devilee, “Tumours of the breast and female genital organs,” in World Health Organization Classification of Tumors, P. Kleihues and L. Sobin, Eds., IARC Press, Lyon, France, 2003. View at Google Scholar
  4. C. W. Elston and I. O. Ellis, “Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up,” Histopathology, vol. 19, no. 5, pp. 403–410, 1991. View at Google Scholar
  5. E. A. Rakha, M. E. El-Sayed, and M. E. El-Sayed, “Prognostic significance of nottingham histologic grade in invasive breast carcinoma,” Journal of Clinical Oncology, vol. 26, no. 19, pp. 3153–3158, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. D. Rosner and W. W. Lane, “Should all patients with node-negative breast cancer receive adjuvant therapy? Identifying additional subsets of low-risk patients who are highly curable by surgery alone,” Cancer, vol. 68, no. 7, pp. 1482–1494, 1991. View at Google Scholar · View at Scopus
  7. N. J. Bundred, “Prognostic and predictive factors in breast cancer,” Cancer Treatment Reviews, vol. 27, no. 3, pp. 137–142, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. S. E. Singletary, C. Allred, and C. Allred, “Revision of the American Joint Committee on cancer staging system for breast cancer,” Journal of Clinical Oncology, vol. 20, no. 17, pp. 3628–3636, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. D. E. Henson, L. Ries, L. S. Freedman, and M. Carriaga, “Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer: the basis for a prognostic index,” Cancer, vol. 68, no. 10, pp. 2142–2149, 1991. View at Google Scholar · View at Scopus
  10. T. Tot, “The limited prognostic value of measuring and grading small invasive breast carcinomas: the whole sick lobe versus the details within it,” Medical Science Monitor, vol. 12, no. 8, pp. RA170–RA175, 2006. View at Google Scholar · View at Scopus
  11. E. O. Hanrahan, V. Valero, A. M. Gonzalez-Angulo, and G. N. Hortobagyi, “Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; Tla,bN0M0): a review of the literature,” Journal of Clinical Oncology, vol. 24, no. 13, pp. 2113–2122, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. P. Leitner, A. S. Swern, D. Weinberger, L. J. Duncan, and R. V. P. Hutter, “Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0),” Cancer, vol. 76, no. 11, pp. 2266–2274, 1995. View at Google Scholar · View at Scopus
  13. P. P. Rosen and S. Groshen, “Factors influencing survival and prognosis and early breast carcinoma (T1N0M0-T1N1M0): assessment of 644 patients with median follow-up of 18 years,” Surgical Clinics of North America, vol. 70, no. 4, pp. 937–962, 1990. View at Google Scholar · View at Scopus
  14. H. Joensuu, L. Pylkkänen, and S. Toikkanen, “Late mortality from pT1N0M0 breast carcinoma,” Cancer, vol. 85, no. 10, pp. 2183–2189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Reed, E. Hannisdal, P. J. Boehler, S. Gundersen, H. Host, and J. M. Nesland, “The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years,” Cancer, vol. 88, no. 4, pp. 804–813, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Frkovic-Grazio and M. Bracko, “Long term prognostic value of Nottingham histological grade and its components in early (pT1n0m0) breast carcinoma,” Journal of Clinical Pathology, vol. 55, no. 2, pp. 88–92, 2002. View at Google Scholar · View at Scopus
  17. J. Kollias, C. A. Murphy, C. W. Elston, I. O. Ellis, J. F. R. Robertson, and R. W. Blarney, “The prognosis of small primary breast cancers,” European Journal of Cancer, vol. 35, no. 6, pp. 908–912, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Tabár, H. H. Chen, and S. W. Duffy, “A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study,” The Lancet, vol. 355, no. 9202, pp. 429–433, 2000. View at Google Scholar
  19. L. Tabár, H. H. Chen, and S. W. Duffy, “A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study,” The Lancet, vol. 355, no. 9212, p. 1372, 2000. View at Google Scholar
  20. J. J. James, A. J. Evans, S. E. Pinder, R. D. Macmillan, A. R. M. Wilson, and I. O. Ellis, “Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?” Clinical Radiology, vol. 58, no. 1, pp. 54–62, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Lundin, M. Lundin, and M. Lundin, “Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study,” Journal of Clinical Oncology, vol. 19, no. 1, pp. 28–36, 2001. View at Google Scholar · View at Scopus
  22. J. A. Bowersox, “National institutes of health consensus development conference statement: adjuvant therapy for breast cancer,” Journal of the National Cancer Institute, vol. 93, no. 13, pp. 979–989, 2001. View at Google Scholar
  23. L. A. Habel, S. Shak, and S. Shak, “A population-based study of tumor gene expression and risk of breast cancer death among lymp node-negative patients,” Breast Cancer Research, vol. 8, no. 3, article no. R25, 2006. View at Publisher · View at Google Scholar · View at PubMed
  24. S. Paik, G. Tang, and G. Tang, “Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer,” Journal of Clinical Oncology, vol. 24, no. 23, pp. 3726–3734, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. Colozza, E. Azambuja, F. Cardoso, C. Sotiriou, D. Larsimont, and M. J. Piccart, “Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?” Annals of Oncology, vol. 16, no. 11, pp. 1723–1739, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. C. Sotiriou, P. Wirapati, and P. Wirapati, “Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis,” Journal of the National Cancer Institute, vol. 98, no. 4, pp. 262–272, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. L. Tabar, H.-H. T. Chen, and H.-H. T. Chen, “Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma: suggestions for the reconsideration of current therapeutic practice and the TNM classification system,” Cancer, vol. 101, no. 8, pp. 1745–1759, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. S. Paik, S. Shak, and S. Shak, “A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer,” New England Journal of Medicine, vol. 351, no. 27, pp. 2817–2826, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus